Chapter 140 - aneurysms caused by connective tissue abnormalities Flashcards

1
Q

Connective tissue disease that lead to aneurysms

A

1) Marfan syndrome 2) Vascular type of Ehlers-Danlos (EDS IV or VEDS) 3) Loeys-Dietz 4) familial thoracic aortic aneurysm and dissection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Connective tissue disease define

A

1) genetic disease 2) primary target is collagen or elastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Structural elements of blood vessels

A

TABLE 140.1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First description of Marfan

A

1896 Antonin-Bernard Marfan 1943 first full description

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Marfan epidemiology

A

1) 2-3/10000 2) autosomal dominant 3) 25% sporadic de novo mutation 4) no gender predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cause of death in marfan

A

1) aortic rupture 2) aortic dissection 3) valvular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathogenesis of Marfan

A

1) Fibrillin-1 (FBN1) mutation 2) failure to maintain normal elastic fibers 3) matrix metalloproteinase 2 and 9 4) inflammation and calcification weakens elastic fibers ALSO 2) TGF beta complex cannot bind microfibril 3) excessive TGF beta signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ghent criteria for Marfan 2010 revised

A

BOX 140.1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Criteria for causal FBN1 mutation

A

BOX 140.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MASS phenotype

A

1) Mitral valve prolapse 2) myopia 3) mild aortic root dilatation 4) striae 5) mild skeletal changes FBN1 mutation created premature termination codons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Shprintzen-Goldberg syndrome

A

1) craniosynostosis 2) facial hypoplasia 3) anterior chest deformity 4) arachnodactyly 5) aortic root dilatation 6) developmental delay FBN1 point mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Locus of marfan disease genetic chromosome

A

15q21.1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Homocystinuria

A

Deficiency of cystathionine beta-synthase 1) long bone overgrowth 2) ectopia lentis 3) NO aortic enlargement 4) mental retardation 5) thromboembolism 6) coronary disease 7) elevated homocysteine autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Congenital contractural arachnodactyly

A

1) NO ocular and cardiovascular manifestation FBN2 gene mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Differential for Marfan

A

1) MASS phenotype 2) Shprintzen-Goldberg syndrome 3) Homocystinuria 4) Congenital contractural arachnodactyly 5) Loeys Dietz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Marfan manifestation

A

1) ocular 2) skeletal 3) cardiovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When does aortic root dilatation begin in Marfan

A

In utero

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Indication to repair aortic root in Marfan

A

1) children growth > 1cm/yr 2) Z score > 2-3 SD 3) adult > 5cm 4) family history of dissection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Z score define

A

Nomogram defining the number of SD of the patient aortic root diameter from mean diameter of population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prevention of aortic root disease in Marfan

A

Avoid burst exertions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Medical treatment of Marfan aortic root growth

A

1) beta-blocker 2) losartan (also reduces TBAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Target HR in Marfan

A

70 beats/min at rest 100 beats/min with exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Beta blocker effect weaker when these conditions occur

A

1) heavier patient 2) diameter > 4cm already

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Losartan regimen in Marfan

A

maximum 2mg/kg up to 100 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Indication for surgical repair in Marfan
1) aortic root \> 5cm 2) arch and descending \> 5.5-6 cm 3) symptomatic
26
First thoracoabdominal aortic repair in marfan
Crawford 1980
27
Long term mortality and spinal cord injury in marfan vs atherosclerotic disease
Lower mortality and lower risk of spinal ischemia in Marfan's
28
Key long term complicadtion of open aortic repair in Marfan
Visceral patch degeneration into aneurysm Repair when 6cm or larger
29
SINE stands for what in terms of endo aortic repair
Stent-graft induced new entry tears
30
Rate of new dissection in endo repair of marfan aorta
25% mortality is 42% after treatment failure
31
Subtypes of Ehlers-Danlos
TABLE 140.2
32
Pathogenesis of type 4 EDS
defective type 3 procollagen (COL3A1 gene)
33
Epiedmiology of EDS 4 and genetics
1) 1 in 50000-90000 2) autosomal dominant 3) 50% are de novo 4) each family carries a unique mutation in COL3A1 gene
34
EDS4 life expectancy
48 (6-73) years
35
Natural history of EDS4
1) Age 20 25% had complication 2) Age 40, 89% major complication vascular and GI and reproductive
36
Cause of death in EDS4
1) vascular rupture 60% 2) CNS hemorrhage 7% 3) unspecified bleed 12% 4) organ rupture 10% 5) intestinal rupture 8%
37
COL3A1 gene function
1) Codes proal(III) = procollagen molecule 2) 3 procollagen molecule form alpha chain triple helix 3) mutation prevents triple helix and are degraded before being secreted extracellularly
38
Diagnostic criteria for EDS4
MAJOR 1) thin translucent skin 2) arterial/intestinal/uterine fragility or rupture 3) extensive bruising 4) characteristic facial appearance MINOR 1) acrogeria (taut thin skin) 2) hypermobility of small joints 3) tendon and muscle rupture 4) talipes equinovarus (clubfoot) 5) early onset varicose veins 6) AV carotid-cavernous sinus fistula 7) pneumothorax/pneumohemothorax 8) gingival recession 9) positive family history, sudden death in one or more close relatives
39
Testing for EDS4
Direct molecular genetic analysis of COL3A1 gene from serum sample
40
Most often type of dissections in EDS4
Medium sized vessels unlike MFS where it's mostly in aorta
41
Differentiating between EDS4 and LDS in terms of arterial tortuosity syndrome
Surgery well tolerated in LDS but not in EDS4
42
Anesthesia considerations in treating EDS4
1) cross match adequate blood 2) avoid IM injections 3) ensure adequate peripheral access 4) avoid art line and CVC 5) gentle intubation maneuvers
43
Rate of true aneurysms in EDS4
14%
44
Complication rate and mortality in EDS4 from access site
67% complication, 12% mortality
45
Suture techniques for bleeds in EDS4
1) vessel ligation with umbilical tape when possible 2) pledgetted tensionless reconstruction 3) circumferentially reinforced
46
Signs that EDS4 patient has inoperable tissue fragility
1) identified \< 20 years old 2) multiple asymptomatic dissection/aneurysms noted
47
Nonvascular complications in EDS4
GI perforation 25% - sigmoid most common - ostomy first
48
Rate of recurrent bowel perf in EDS4
17% in 26 years
49
Non-surgical treatment of EDS4
1) celiprolol (controversial) 2) BP control 3) lifestyle modifications 4) Factor VII transfusion
50
Hopkins 1994-2009 recommendation in EDS4
1) liberal use of adjunctive technique to reduce operative trauma 2) padded surgical clamps 3) permissive hypotension (SBP 70-80) during clamp and anastamosis testing
51
Unique iliac aneurysms in EDS4
1) spares aortic bifurcation 2) bell-bottom CIA
52
Role of endo in EDS4
1) generally do not use 2) access site problem needs open repair 3) embolization of aortic branch and medium vessel and carotid-cavernous sinus fistula can work
53
Maternal mortality in 2 weeks post partum in EDS4
15%
54
Loeys Dietz Syndrome classic symptoms
1) aortic syndrome with aneurysm and vascular tortuosity 98% 2) craniaofacial abn (bifid uvula, cleft palate) 90% 3) hypertelorism (90%) 4) craniosynostosis (premature closure of skull) 48% 5) malar hypoplasia (flat midface) 60% 6) blue sclerae 40%
55
Gene mutation in LDS
1) Heterozygous mutation 2) TGF beta receptor 1 and 2 (TGFBR1, TGFBR2) 3) SMAD3 4) TGF-B2 receptor
56
Subtypes of LDS
TYPE 1: severe craniofacial and aortic aneurysm TYPE 2: less severe craniofacial (bifid uvula or high palate) and aneurysm TYPE 3: aortic aneurysm with early-onset osteoarthritis TYPE 4: aortic aneurysm, cerebral aneurysm, arterial tortuosity
57
Cardinal manifestation of LDS aorta
1) aortic root dilatation 2) rupture and dissect at lower diameters than MFS and EDS4
58
Systemic features in LDS
BOX 140.4
59
Onset of disease in different LDS subtypes
More craniofacial abn = more aggressive aortic path = earlier surgery TYPE 1: first surgery 16.9 years old; death 22.6 years old TYPE 2: first surgery 26.9 years old; death 31.8 years old TYPE 3 and 4 later onset
60
Difference in eye manifestation of LDS from MFS
Lens dislocation (ectopia lentis) only in MFS
61
Size and growth of aortic aneurysm indicating repair in LDS
4 cm growth \> 0.5 cm/year
62
Medical treatment of LDS
beta blocker, losartan (for TGF beta activity) and lifestyle modification no clear evidence
63
How to avoid kinking in visceral aortic repair to the branches
360 degrees wrapping of the branch graft minimize patch inclusion from the vessel wall to prevent patch degeneration and patch aneurysm
64
Familial thoracic aortic aneurysm and dissection definition
1) not MFS, EDS4, LDS 2) 11-19% of all still have first degree relative 3) audosomal dominant with variable penetrance and expression
65
TAAD1 locus 5q13-14 key points
1) autosomal dominant 2) women less affected 3) ascending aorta involvement
66
Pathogenesis of familial TAAD
1) medial degeneration 2) disarray of SMC and accumulation of proteoglycan
67
ACTA2 mutation alpha-actin mutation
1) 14% of familial TAAD 2) low penetrance and does not change with age (different from other TAAD types)
68
Familial TAAD age onset of aneurysm vs sporadic aneurysms
58.2 years vs 65.7 years otherwise normal
69
Aneurysm frequency and types in familial TAAD
1) thoracic 66% 2) AAA 25% 3) cerebral 8-10%
70
Ascending and descending aorta in familial TAAD, aneurysm vs dissection frequency
Ascending aneurysm 82%; dissection 18% Descending aneurysm, dissection 50/50%
71
Size for repair of familial TAAD aneurysms
Same as others 6 thoracic 5.5 abdominal growth is faster 0.21 vs 0.16cm/yr